1. A double-lumen perfusion technique has been used in man to study intestinal absorption of two tripeptides, glycyl-glycyl-glycine and L-alanyl-glycyl-glycine. Intraluminal tripeptide hydrolysis has been investigated by incubating both tripeptides in vitro with fresh uncentrifuged saline aspirates.
now been confirmed in man by using an oral load technique and perfusion techniques (Adibi, 1971 ; Hellier, Holdsworth, McColl & Perrett, 1972a) , and in addition stereospecificity of peptide transport has been demonstrated in man (Silk, Perrett & Clark, 1973a) . It seems likely therefore that uptake of intact dipeptides by the mucosal cells of the small intestine plays a role in the absorption of the products of intraluminal protein digestion. The oral load studies carried out in man showed that glycine was absorbed faster not only from the dipeptide glycyl-glycine but also from the tripeptide glycyl-glycyl-glycine, suggesting a possible role for tripeptide uptake in the absorption of dietary protein. There has been no further information concerning the handling of tripeptides in man but there is now evidence from animal studies in uivo that the mucosal uptake of amino acids is also more rapid from some tripeptides than from equivalent amino acid mixtures (Matthews et al., , 1969 . In view of the results of these animal experiments this study has been undertaken to investigate the handling of tripeptides by the upper small intestine in man.
For these experiments we have used a jejunal perfusion technique to study absorption of the two tripeptides glycyl-glycyl-glycine and L-alanyl-glycyl-glycine. A preliminary report has already appeared (Silk, Perrett, Webb & Clark, 1973b) .
M E T H O D S Experimental procedure
Normal male adult volunteers, aged 21-42 years, who gave their informed consent, were fasted overnight and intubated on the morning of the experiment with a double-lumen perfusion tube (Sladen & Dawson, 1970) . The tube was allowed to pass until the 30 cm perfusion segment was positioned in the upper jejunum. The final position of the tube was checked fluoroscopically so that the infusion orifice was situated in the 10 cm segment of upper jejunum beyond the duodeno-jejunal flexure. A proximal occlusive balloon was incorporated in the perfusion tube to prevent both reflux of the infused solutions from the perfusion segment and contamination of the infused solution within the perfused segment by proximal secretions, in particular by proteolytic pancreatic enzymes. The efficacy of the occluding balloon was checked by injecting a 4 ml bolus of Phenol Red through an additional lumen with an opening immediately proximal to the balloon. All perfusion solutions were infused at a rate of 15 ml/min through the infusion orifice with a peristaltic pump (H. R. Flow Inducer, Watson-Marlow Ltd, Marlow, Bucks.) from bottles maintained at 37°C in a water bath. The first 30 min of each perfusion period was allowed for the attainment of a steady state in absorption rates. Preliminary studies indicated that this interval was sufficient for this purpose. Three 10 min collections were then obtained by a process of simple siphonage through the aspiration orifice. The samples were collected into plastic bottles containing sufficient sulphosalicylic acid to produce a final pH of approximately 2.0. After collection, the aspirated samples were filtered through Whatman no. 1 filter paper, and the filtrates stored at -20°C until analysis.
Experimental design
Four experiments were carried out, and a different group of subjects was studied in each experiment. In experiment 1, glycine absorption was compared from solutions containing 3-3 mmol/l glycyl-glycyl-glycine, 5 mmol/l glycyl-glycine and 10 mmol/l glycine. In experiment 2, glycine and L-alanine absorption were compared from solutions containing 10 mmol/l L-alanyl-glycyl-glycine and 10 mmol/l L-alanine + 20 mmol/l glycine. In experiment 3, glycine and L-alanine absorption were compared from solutions containing 10 mmol/l L-alanylglycyl-glycine and 10 mmol/l L-alanine + 10 mmol/l glycyl-glycine, and in experiment 4, glycine absorption from 10 mmol/l glycyl-glycyl-glycine was studied. The statistical significance of differences in absorption rates within groups was evaluated by the paired t-test (Snedecor, 1937) .
Solutions
The amino acids glycine and L-alanine, and the peptides glycyl-glycine, glycyl-glycyl-glycine and L-alanyl-glycyl-glycine, were obtained from Sigma (London) Chemical Co. They were all found to be chromatographically homogeneous. All solutions were made isotonic by adding sodium chloride and contained the non-absorbable marker polyethylene glycol at a concentration of 2.5 g/1 (Schedl, 1966) . Solutions studied in experiments 2 and 3 also contained 1 pCi of [14C]polyethylene glycol per litre (New England Nuclear Corporation, Boston, Massachusetts, USA.). Preliminary studies (n = 62) showed that polyethylene glycol + [14C]polyethylene glycol measured turbidimetrically and by liquid-scintillation counting yielded similar results of water movement. The pH of all solutions was adjusted to pH 7.0 by titrating with molar sodium hydroxide solution.
Estimation of intraluminal peptidase
The two tripeptides were incubated in vitro with fresh uncentrifuged aspirates, obtained during perfusion of unbuffered isotonic sodium chloride solution (PH adjusted to 7.0) to simulate intraluminal tripeptide hydrolysis. L-Alanyl-glycyl-glycine was incubated with the aspirated luminal contents obtained when the six subjects in experiment 2 were perfused with isotonic sodium chloride. Glycyl-glycyl-glycine was incubated with similar aspirates obtained from a further seven subjects.
Unbuffered tripeptide (0-1 ml, 0-4 mol/l) was added to 4 ml of aspirate, and this mixture, containing a final concentration of tripeptide of 10 mmol/l, was incubated in a shaking water bath maintained at 37°C and the peptide digestion terminated after 15 min by acidifying with crystals of sodium ethylenediamine tetra-acetate; the samples were stored at -20°C until analysis. The initial and final concentrations of tripeptide, and final concentrations of the breakdown products, were estimated by using ion-exchange chromatography as detailed below. The statistical significance of differences in hydrolysis rates and final concentrations of accumulated hydrolytic products were evaluated by the paired and unpaired t-test where appropriate (Snedecor, 1937) .
Estimation of transit times
Estimates of the total transit time were carried out in six subjects after aspirates had been collected during the perfusion of isotonic sodium chloride solution. A 50 mg bolus of bromosulphophthalein in 1 ml was injected into the infusion lumen of the perfusion tube, and dyedilution curves were constructed (Dillard, Eastman & Fordtran, 1965) . The mean total transit time was 10.3+2*0 min (mean+ 1 SEM, n = 6).
Chemical analysis
The polyethylene glycol content of the perfusion solutions and the intestinal aspirates was measured turbidimetrically (Hyden, 1955) . The [14C]polyethylene glycol was measured in a scintillation counter (Tracer Lab Corumatric 200 liquid-scintillation counter) with an external standard; toluene containing 4 g/l of 2,5-diphenyloxazol~Triton X-100 (3:l) was used as a scintillation mixture. The tonicity of the perfusion solutions was measured with an osmometer (Advanced Osmometer, Advanced Instruments Inc., Massachusetts, U.S.A.) and the pH of the perfusion solutions was checked with a pH meter.
Ion-exchange chromatography
Glycine, L-alanine, L-alanyl-glycyl-glycine and its hydrolysis products were quantified by using a Technicon NC-1 amino acid analyser. Appropriate aliquots (0.2-0.5 pmol) of the perfusion solutions and intestinal aspirates were applied to a 140 cm x 0.63 cm column packed with Technicon Chromobeads type B. The column was eluted with the buffer system described by Purdie, Cravelle & Hanafi (1968) , and norleucine was used as an internal standard. The elution times were 271 rnin for glycine, 303 rnin for L-alanine, 387 rnin for L-alanyl-glycylglycine, 424 rnin for L-alanyl-glycine, 439 min for glycyl-glycine and 538 rnin for norleucine.
It was not possible to separate glycyl-glycyl-glycine from glycyl-glycine by the above technique, a difficulty that has been encountered with another buffer system (Hamilton, 1963) . Although a technique has been described which separates these two compounds in 6 h (Peters & MacMahon, 1970) , we developed a system capable of resolving these two compounds in approximately 1 h. Aliquots of the perfusion solutions and intestinal aspirates (0.1 pmol) were applied to a 20 cm x 0-63 cm column packed with Technicon Chromobeads type B (bed height 16 cm). The column was eluted at 80°C with sodium citrate buffer (pH 2-40, sodium molarity 0.2 mol/l) containing 1 mmol/l sodium ethylenediamine tetra-acetate and 0.4 g/lOO ml BRIJ 35 (polyoxyethylene lauryl ether; BDH Chemicals Ltd) at a flow rate of 40 ml/min. The elution times were 52 rnin for glycine, 62 rnin for glycyl-glycyl-glycine and 70 min for glycyl-glycine.
Calculation of data
The absorption rates of the amino acids from the perfusion solutions containing free amino acids and dipeptides were calculated by using previously published formulae (Holdsworth & Dawson, 1964; Adibi, 1971) . The net absorption rates of the amino acids from the tripeptide solutions was calculated from the formula where A , = net rate of amino acid absorption(pmo1min-' 30cm-'), n = number of same amino acid residues in the peptide linkage, P, = concentration of tripeptide int he perfusion solution (pmol ml-'), Pa = concentration of tripeptide in the intestinal aspirates (pmol ml-'), D , = concentration of dipeptide in the intestinal aspirates (pmol ml-I), C , = concentration of the same free amino acid in the intestinal aspirates (pmol d-i), [PEG], = concentration of polyethylene glycol in the perfusion solution, [PEG], = concentration of polyethylene glycol in the intestinal aspirates and R = rate of perfusion (ml mind').
The estimated maximum luminal concentration (%) of each breakdown product that could have resulted from intraluminal tripeptide hydrolysis (Ap) was calculated from the formula H Ba 100
where H = rate of appearance of the breakdown product int he peptide digest mixture (pmol ml-' min-'), T = total transit time (min), Ba= the concentration (pmol ml-l) of the same breakdown product aspirated when it was separately perfused at a concentration of 10 pmol ml-' (Bp) and BL = concentration of the same breakdown product aspirated during the tripeptide perfusions (pmol ml-').
RESULTS

Perfusion experiments
The rate of amino acid absorption from the peptide and equivalent amino acid solutions are summarized in Table 1 and the concentrations of free amino acids and dipeptides detected in the luminal contents aspirated during the peptide perfusions are summarized in Table 2 . Experiment 1. Glycine was absorbed faster from 5 mmol/l glycyl-glycine (Pe0.05) and from 3.3 mmol/l glycyl-glycyl-glycine (P< 0.05) solutions than from the equivalent 10 mmol/l glycine solution. There was no significant difference in the rates of glycine absorption from the solutions containing tripeptide as compared with the dipeptide. Similar mean concentrations of free glycine were aspirated during 5 mmol/l glycyl-glycine perfusion (0.3 1 mmol/l) and 3-3 mmol/l glycyl-glycyl-glycine perfusion (0.3 1 mmol/l). Small concentrations of glycyl-glycine were aspirated in addition to free glycine during perfusion of gl ycyl-gl ycyl-gl ycine.
Experiment 2. Both L-alanine (Pt0.01) and glycine (P<O.OOI) were absorbed faster from the tripeptide solution than from the equivalent amino acid solution. The difference between the absorption rates of glycine and L-alanine was greater when the tripeptide solution was perfused than when the amino acid solution was perfused ( P e 0.001).
The amino acids L-alanine and glycine and the dipeptide glycyl-glycine were always detected in the luminal contents aspirated during the 10 mmol/l L-alanyl-glycyl-glycine perfusions (Table 2 ). On two occasions very low concentrations of the dipeptide L-alanyl-glycine were detected. There was no significant difference in the concentrations of free L-alanine and glycine aspirated, but higher concentrations of the dipeptide glycyl-glycine were detected compared with L-alanine (P<O.OOl) and glycine (P<O.O2). The virtual absence of the dipeptide L-alanylglycine in the aspirates suggests that initial hydrolysis of L-alanyl-glycyl-glycine occurs at the N-terminal end of the molecule. Experiment 3. Glycine was absorbed faster than L-alanine from the solutions containing 10 mmol/l L-alanyl-glycyl-glycine and 10 mmol/l L-alanine + 10 mmol/l glycyl-glycine (P < 0.001).
There was no significant difference when the rates of L-alanine and glycine absorption from the two solutions were compared. The mean concentrations of the amino acids L-alanine and glycine and the dipeptide glycyl-glycine detected in the luminal contents aspirated during the 10 mmol/l L-alanyl-glycylglycine perfusions were very similar to those detected when the tripeptide was perfused in experiment 2 (Table 2) . On this occasion, the dipeptide L-alanyl-glycine was not detected in the tripeptide aspirates.
Experiment 4. The mean rate of glycine absorption from 10 mmol/l glycyl-glycyl-glycine was 198.9 pmol min-l 30 cm-l. The mean concentrations of glycine detected in the aspirated luminal contents was 1-12 mmol/l and glycyl-glycine 0.65 mmol/l. There was no significant difference in the luminal concentration of glycyl-glycine aspirated during the perfusion of 10 mmol/l glycyl-glycyl-glycine and 10 mmol/l L-alanyl-glycyl-glycine.
Intraluminal peptide hydrolase activity
The disappearance rates of the two tripeptides from the incubation mixtures, and the final concentration of tripeptides and breakdown products present in the digest mixtures at the end of the incubation period, are summarized in Table 3 . Glycyl-glycyl-glycine disappeared from the incubation mixture at a slower rate than L-alanyl-glycyl-glycine (P< O.OOl), and the final concentrations of glycyl-glycyl-glycine remaining in the incubation mixture were higher than L-alanyl-glycyl-glycine (P< 0.05). Higher concentrations of the dipeptide glycyl-glycine than L-alanyl-glycine (P< 0.001) were detected in the peptide digest mixture at the end of L-alanylglycyl-glycine incubation. These results in vitro thus confirm the suggestion that initial hydrolysis of the tripeptide L-alanyl-glycyl-glycine occurs at the N-terminal end of the molecule.
The estimated maximal luminal concentrations (%) of the breakdown products aspirated during the 10 mmol/l tripeptide perfusions, which could be due to intraluminal tripeptide hydrolysis, are also shown in Table 3 . Although 58.8% of the very low concentrations of free L-alanyl-glycine detected in the luminal contents aspirated during L-alanyl-glycyl-glycine perfusion could have resulted from intraluminal hydrolysis, less than 25% of the luminal concentration of the other breakdown products detected in the tripeptide aspirates could have been due to intraluminal tripeptide hydrolysis.
DISCUSSION
Perfusion techniques have previously been used to study dipeptide absorption in man (Adibi, 1971; Hellier et al., 1972a; Hellier, Holdsworth, Perrett & Thirumalai, 1972b; Silk et al., 1973a) . The concentrations of free amino acids and dipeptides in the aspirated luminal contents have been measured, and dipeptide absorption quantified. In view of the recent observation that given quantities of glycine administered orally in man as the tripeptide glycyl-glycyl-glycine are absorbed faster than equivalent doses of free glycine , we have used a perfusion technique in vivo to further investigate the absorption of the tripeptide glycyl-glycyl-glycine and to investigate absorption of L-alanyl-glycyl-glycine, a tripeptide not previously studied in man.
Although preliminary experiments showed that L-alanyl-glycyl-glycine and its hydrolysis products could be separated and quantified by using a Technicon NCI analyser, such separation of glycyl-glycyl-glycine and its hydrolysis products could only be achieved by modifying existing methods and using a shorter column, a higher temperature and a different buffer system.
Our perfusion experiments showed that glycine was absorbed at similar rates from the tripeptide glycyl-glycyl-glycine and the dipeptide glycyl-glycine. In contrast, using an oral load technique, Craft et al. (1968) showed that glycine was absorbed faster from the tripeptide than the dipeptide. One explanation of these differences could be that higher osmotic loads were administered in the oral load experiments; alternative explanations are awaited from further studies.
Theoretically, before absorption takes place, tripeptides could be hydrolysed within the lumen of the small intestine, and the liberated dipeptides and amino acids transported into the mucosal cell. An attempt has been made in this study to simulate intraluminal tripeptide hydrolysis ; both tripeptides were incubated in vitro with fresh saline aspirates, and an approximate estimate of intraluminal hydrolysis was made. The results showed that the luminal contents aspirated during the unbuffered saline perfusions contained enzymes which were capable of hydrolysing both glycyl-glycyl-glycine and L-alanyl-glycyl-glycine. L-Alanyl-glycyl-glycine was hydrolysed faster than glycyl-glycyl-glycine (Table 3) . A previous study (Silk et al., 1973a) showed that when the two dipeptides L-alanyl-glycine and glycyl-L-alanine were incubated with soluble intraluminal enzymes, L-alanyl-glycine, the dipeptide with an N-terminal L-alanine molecule, was hydrolysed faster than glycyl-L-alanine. It seems likely therefore that intraluminal peptidases have a preference for N-terminal L-alanine rather than N-terminal glycine of dipeptides as well as tripeptides.
The calculations based on the experiments in vitro showed that less than 25% of the total concentration of the amino acids L-alanine and glycine, and the dipeptide glycyl-glycine aspirated during the 10 mmol/l tripeptide perfusions, could have been due to intraluminal tripeptide hydrolysis. The calculations relating to L-alanyl-glycine are not helpful as such low concentrations of the dipeptide were aspirated during 10 mmol/l L-alanyl-glycyl-glycine perfusion.
The perfusion experiments in vivo confirmed the findings in uitro that significant intraluminal tripeptide hydrolysis does not occur before absorption takes place, as the constituent amino acids glycine and L-alanine were both absorbed faster from the tripeptide solutions than from the equivalent amino acid solutions, and low concentrations of amino acids and dipeptides were aspirated during the perfusions.
The concentration of free amino acids and dipeptides aspirated during the tripeptide perfusions not accounted for by intraluminal tripeptide hydrolysis, must be related to mucosal cell enzyme activity. Cell-fractionation studies have shown that there are enzymes in the brush border and soluble fractions of the guinea-pig intestinal mucosa capable of hydrolysing both tripeptides , and in the brush border and cytosol fraction of the rat intestinal mucosa cell capable of hydrolysing L-alanyl-glycyl-glycine (Kim, Kim & Sleisenger, 1973) . The liberated amino acids and dipeptides could thus diffuse back into the luminal contents after brush-border tripeptide hydrolysis, or efflux out of the mucosal cell after intracellular tripeptide hydrolysis.
It is not clear whether membrane hydrolysis is a prerequisite during tripeptide transport, the released amino acids and dipeptides being recaptured by amino acid-and dipeptide-uptake systems, or whether the tripeptides share dipeptide-uptake systems. Further studies are therefore needed before firm conclusions can be drawn about the exact mechanisms involved in tripeptide transport.
